Morgan Stanley Becton Dickinson & CO Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Becton Dickinson & CO stock. As of the latest transaction made, Morgan Stanley holds 10,980,225 shares of BDX stock, worth $2.46 Billion. This represents 0.2% of its overall portfolio holdings.

Number of Shares

10,980,225

Previous 11,330,104 3.09%

Holding current value

$2.46 Billion

Previous $2.65 Billion 0.02%

% of portfolio

0.2%

Previous 0.21%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $77.5 Million - $84.8 Million	-349,879 Reduced 3.09%	10,980,225 $2.65 Billion
Q2 2024 Oct 17, 2024	BUY	$225.07 - $246.17 $139 Million - $152 Million	617,180 Added 5.76%	11,330,104 $2.65 Billion
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $139 Million - $152 Million	617,180 Added 5.76%	11,330,104 $2.65 Billion
Q1 2024 Oct 17, 2024	SELL	$233.45 - $247.73 $144 Million - $153 Million	-617,180 Reduced 5.45%	10,712,924 $2.65 Billion
Q1 2024 Aug 16, 2024	BUY	$233.45 - $247.73 $320,059 - $339,637	1,371 Added 0.01%	10,712,924 $2.65 Billion
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $320,059 - $339,637	1,371 Added 0.01%	10,712,924 $2.65 Billion
Q4 2023 Aug 16, 2024	SELL	$232.24 - $267.23 $144 Million - $165 Million	-618,551 Reduced 5.46%	10,711,553 $2.61 Billion
Q4 2023 Feb 13, 2024	BUY	$232.24 - $267.23 $119 Million - $137 Million	511,340 Added 5.01%	10,711,553 $2.61 Billion
Q3 2023 Nov 15, 2023	BUY	$254.9 - $283.59 $111 Million - $123 Million	435,168 Added 4.46%	10,200,213 $2.64 Billion
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $311 Million - $346 Million	1,305,498 Added 15.43%	9,765,045 $2.58 Billion
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $21.8 Million - $24.6 Million	-94,693 Reduced 1.11%	8,459,547 $2.09 Billion
Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $29.6 Million - $34.8 Million	-135,475 Reduced 1.56%	8,554,240 $2.18 Billion
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $14.7 Million - $76 Million	-287,735 Reduced 3.21%	8,689,715 $1.94 Billion
Q2 2022 Oct 27, 2022	BUY	$234.74 - $275.42 $274 Million - $322 Million	1,168,614 Added 14.97%	8,977,450 $2.21 Billion
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $274 Million - $322 Million	1,168,614 Added 14.97%	8,977,450 $2.21 Billion
Q1 2022 Oct 27, 2022	SELL	$243.64 - $270.48 $285 Million - $316 Million	-1,168,614 Reduced 13.02%	7,808,836 $2.08 Billion
Q1 2022 May 13, 2022	SELL	$243.64 - $270.48 $407 Million - $452 Million	-1,670,964 Reduced 17.63%	7,808,836 $2.08 Billion
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $80.1 Million - $87.3 Million	-348,075 Reduced 3.54%	9,479,800 $2.38 Billion
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $2.29 Billion - $2.52 Billion	9,827,875 New	9,827,875 $2.42 Billion

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account